[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.16″ custom_padding=”0px|||||” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row admin_label=”row” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_padding=”||4px|||” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||” theme_builder_area=”post_content”][et_pb_text admin_label=”Text” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” min_height=”119px” custom_padding=”0px|||||” global_colors_info=”{}” theme_builder_area=”post_content”]<\/p>\n
Peter, a 72-year-old retired engineer, was diagnosed with T1 high-grade (HG) non-muscle-invasive bladder cancer (NMIBC) 18 months ago. Following a successful transurethral resection of the bladder tumour (TURBT) and re-TURBT without further pathology, he received a full induction course of bacillus Calmette-Gu\u00e9rin (BCG) therapy followed by maintenance BCG.<\/span><\/p>\n At his initial 3-month follow-up cystoscopy, he was confirmed disease-free. According to standard guidelines for high-risk NMIBC, Peter’s surveillance schedule involves frequent cystoscopies and urinary cytology every 3 months for the first 2 years.<\/span><\/p>\n During his next follow-up visit, Peter raises that these frequent, invasive cystoscopies cause him significant anxiety well ahead of each appointment. The continuous need for hospital visits also disrupts his otherwise active retirement, adding a considerable burden to his daily life. Moreover, he experienced a urinary tract infection (UTI) following last cystoscopy leading to delay of maintenance BCG instillation.<\/span><\/p>\n <\/span><\/p>\n Cast your vote and see what Prof. Prof. J\u00f8rgen Bjerggaard recommends for this patient case!<\/strong><\/p>\n [\/et_pb_text][et_pb_text admin_label=”Text” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_margin=”||0px||false|false” custom_padding=”||0px|||” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.16″ _module_preset=”default” width=”73.7%” custom_margin=”|auto||150px||” custom_padding=”|||0px||” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_button button_url=”https:\/\/bcamonitor.mirrorsmed.org\/en\/single-case\/9qqhcpl7tzk8soww8gs8wgggo8k8wkw?answer=caseAnswer1″ url_new_window=”on” button_text=”A” button_alignment=”center” _builder_version=”4.16″ _module_preset=”default” custom_button=”on” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_button button_url=”https:\/\/bcamonitor.mirrorsmed.org\/en\/single-case\/9qqhcpl7tzk8soww8gs8wgggo8k8wkw?answer=caseAnswer2″ url_new_window=”on” button_text=”B” button_alignment=”center” _builder_version=”4.16″ _module_preset=”default” custom_button=”on” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_button button_url=”https:\/\/bcamonitor.mirrorsmed.org\/en\/single-case\/9qqhcpl7tzk8soww8gs8wgggo8k8wkw?answer=caseAnswer3″ url_new_window=”on” button_text=”C” button_alignment=”center” _builder_version=”4.16″ _module_preset=”default” custom_button=”on” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.16″ _module_preset=”default” width=”74.1%” module_alignment=”center” min_height=”119px” custom_margin=”|-10px||150px||” custom_padding=”|0px||0px||” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.16″ _module_preset=”default” link_option_url=”https:\/\/bcamonitor.mirrorsmed.org\/en\/single-case\/9qqhcpl7tzk8soww8gs8wgggo8k8wkw?answer=caseAnswer1″ link_option_url_new_window=”on” global_colors_info=”{}” theme_builder_area=”post_content”]<\/p>\n Continue with routine, frequent cystoscopies<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.16″ _module_preset=”default” link_option_url=”https:\/\/bcamonitor.mirrorsmed.org\/en\/single-case\/9qqhcpl7tzk8soww8gs8wgggo8k8wkw?answer=caseAnswer2″ link_option_url_new_window=”on” global_colors_info=”{}” theme_builder_area=”post_content”]<\/p>\n Alternate urinary biomarker with cystoscopy; performing an earlier cystoscopy only if the urinary test yields a positive or unconclusive result<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.16″ _module_preset=”default” link_option_url=”https:\/\/bcamonitor.mirrorsmed.org\/en\/single-case\/9qqhcpl7tzk8soww8gs8wgggo8k8wkw?answer=caseAnswer3″ link_option_url_new_window=”on” global_colors_info=”{}” theme_builder_area=”post_content”]<\/p>\n Discontinue all regular surveillance visits, relying solely on symptom-driven investigations for recurrence<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.16″ global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.16″ global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.16″ global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_text][et_pb_button button_url=”https:\/\/bcamonitor.org\/slides-brochure\/” button_text=”Download the free slide resource and brochure” button_alignment=”center” _builder_version=”4.16″ custom_button=”on” button_text_color=”#ffffff” button_bg_color=”#3b8dbf” button_border_width=”0px” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.8.2″ _module_preset=”default” custom_padding=”2px||5px|||” global_module=”303″ saved_tabs=”all” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" Peter, a 72-year-old retired engineer, was diagnosed with T1 high-grade (HG) non-muscle-invasive bladder cancer (NMIBC) 18 months ago. Following a successful transurethral resection of the bladder tumour (TURBT) and re-TURBT without further pathology, he received a full induction course of bacillus Calmette-Gu\u00e9rin (BCG) therapy followed by maintenance BCG. At his initial 3-month follow-up cystoscopy, he […]<\/p>\n","protected":false},"author":0,"featured_media":291,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[11],"tags":[],"class_list":["post-352","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinicalcase"],"_links":{"self":[{"href":"https:\/\/bcamonitor.org\/index.php?rest_route=\/wp\/v2\/posts\/352","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bcamonitor.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bcamonitor.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bcamonitor.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=352"}],"version-history":[{"count":1,"href":"https:\/\/bcamonitor.org\/index.php?rest_route=\/wp\/v2\/posts\/352\/revisions"}],"predecessor-version":[{"id":359,"href":"https:\/\/bcamonitor.org\/index.php?rest_route=\/wp\/v2\/posts\/352\/revisions\/359"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bcamonitor.org\/index.php?rest_route=\/wp\/v2\/media\/291"}],"wp:attachment":[{"href":"https:\/\/bcamonitor.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=352"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bcamonitor.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=352"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bcamonitor.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=352"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}